DaVita (NYSE:DVA) Reaches New 52-Week High – What’s Next?

Shares of DaVita Inc. (NYSE:DVA) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $203.54 and last traded at $202.8560, with a volume of 208617 shares changing hands. The stock had previously closed at $198.54.

Analyst Upgrades and Downgrades

DVA has been the topic of a number of recent research reports. UBS Group lifted their target price on DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Weiss Ratings restated a “hold (c+)” rating on shares of DaVita in a report on Monday. TD Cowen raised their target price on DaVita from $144.00 to $201.00 and gave the stock a “hold” rating in a research report on Monday, May 11th. Wall Street Zen raised DaVita from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. Finally, Truist Financial raised their target price on DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a research report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $199.17.

DaVita Stock Up 2.7%

The stock has a market cap of $13.08 billion, a price-to-earnings ratio of 18.90, a PEG ratio of 0.65 and a beta of 0.91. The business has a 50-day moving average of $173.98 and a 200-day moving average of $145.06.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. The firm had revenue of $3.42 billion during the quarter, compared to analysts’ expectations of $3.36 billion. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The business’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Equities analysts anticipate that DaVita Inc. will post 15.07 earnings per share for the current year.

Insider Transactions at DaVita

In related news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the completion of the sale, the chief financial officer owned 132,434 shares of the company’s stock, valued at approximately $25,440,571.40. This trade represents a 27.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.50% of the company’s stock.

Institutional Trading of DaVita

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Invesco Ltd. lifted its position in shares of DaVita by 2.0% in the third quarter. Invesco Ltd. now owns 1,679,248 shares of the company’s stock worth $223,122,000 after buying an additional 32,358 shares during the last quarter. Morgan Stanley increased its stake in shares of DaVita by 5.1% in the fourth quarter. Morgan Stanley now owns 1,477,045 shares of the company’s stock worth $167,807,000 after purchasing an additional 71,156 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in shares of DaVita by 114.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,190,000 shares of the company’s stock worth $135,196,000 after purchasing an additional 636,191 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of DaVita by 5.2% in the first quarter. Dimensional Fund Advisors LP now owns 1,145,436 shares of the company’s stock worth $176,037,000 after purchasing an additional 56,336 shares during the period. Finally, LSV Asset Management increased its stake in shares of DaVita by 1.1% in the fourth quarter. LSV Asset Management now owns 936,768 shares of the company’s stock worth $106,426,000 after purchasing an additional 9,739 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.